Pharmacogenetics

Research Frontiers in N-Acetyltransferase 1 Variants in Doxorubicin Cardiotoxicity

Investigation of NAT1 polymorphisms affecting acetylation of doxorubicin metabolites and predicting cardiac toxicity risk in breast cancer chemotherapy recipients.

All Pharmacogenetics PhD categories